Dihydroartemisinin Ameliorates Cerebral I/R Injury in Rats Via Regulating VWF and Autophagy-mediated SIRT1/FOXO1 Pathway
Overview
Affiliations
Dihydroartemisinin (DHA) has been found to inhibit the expression of von Willebrand factor (VWF), a marker of endothelial cell injury, but its mechanism in cerebral ischemia/reperfusion (I/R) injury remains obscure. In this study, I/R model was constructed through middle cerebral artery occlusion (MCAO) in rats, followed by DHA administration. The effect of DHA on rat cerebral I/R injury was investigated by 2,3,5-triphenyltetrazolium chloride staining, hematoxylin and eosin staining, TUNEL staining, and Western blot. Brain microvascular endothelial cells (BMVECs) isolated from newborn rats were exposed to oxygen-glucose deprivation/reoxygenation (OGD/R), and then treated with DHA. The results showed that MCAO treatment induced infarction, nerve cell apoptosis, and brain tissue impairment in rats, which was mitigated by DHA. OGD/R inhibited viability and accelerated apoptosis of BMVECs, which was alleviated by DHA. I/R procedures or OGD/R up-regulated expressions of VWF, ATG7, Beclin1, and LC3-II/LC3-I ratio, while down-regulating Occludin, Claudin-5, ZO-1, P62, SIRT1, and FOXO1 expressions and ; however, these effects of I/R procedures or OGD/R were offset by DHA. VWF overexpression reversed the above effects of DHA on OGD/R-induced BMVECs. In summary, DHA ameliorates cerebral I/R injury in rats by reducing VWF level and activating autophagy-mediated SIRT1/FOXO1 signaling pathway.
Gao Y, Li L, Zhao F, Cheng Y, Jin M, Xue F Drug Des Devel Ther. 2025; 19:369-387.
PMID: 39867864 PMC: 11760763. DOI: 10.2147/DDDT.S504179.
Jiang Y, He H, Jia X J Biochem Mol Toxicol. 2025; 39(2):e70151.
PMID: 39865943 PMC: 11837462. DOI: 10.1002/jbt.70151.
From Microcirculation to Aging-Related Diseases: A Focus on Endothelial SIRT1.
Law M, Wang P, Zhou Z, Wang Y Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598406 PMC: 11597311. DOI: 10.3390/ph17111495.